About REMED
REMED grows with its customers.
REMED has been producing and supplying core components and medical devices related to electronic medication, focusing on "treatment of intractable brain diseases" and "non-invasive procedures," since its establishment 20 years ago. From the early stages of the development of major neural modulation technologies in Korea such as Transcranial Magnetic Stimulation (TMS), Neural Magnetic Stimulation (NMS), and Core Strength Magnetic Stimulation (CSMS), REMED has been growing with customers based on deep-rooted trust.
REMED strives to provide greater added value and satisfaction as a specialized company in the field of electronic medication. Based on the technology and experience accumulated so far, REMED aims to expand clinical indications, strengthen overseas businesses in the US, Europe, and China, and achieve sustainable growth.
Furthermore, by supplying more technologically differentiated products and solutions, REMED aims to become the undisputed global No.1 specialized company in electronic medication. REMED will be a company that fulfills robust social responsibilities and builds a sustainable corporate ecosystem.
Mission & Vision
History